Business NewsPR NewsWire • Nestlé commences tender offer for Aimmune Therapeutics, Inc.

Nestlé commences tender offer for Aimmune Therapeutics, Inc.

Nestlé commences tender offer for Aimmune Therapeutics, Inc.

VEVEY, Switzerland, Sept. 14, 2020 /PRNewswire/ -- Société des Produits Nestlé S.A. ("Nestlé") announced that its wholly-owned subsidiary, SPN Merger Sub, Inc. ("Purchaser"), is commencing today a cash tender offer to purchase all of the outstanding shares of common stock of Aimmune...

View More : https://www.prnewswire.com:443/news-releases/nestle-commences-tender-offer-for-aimmune-therapeutics-inc-301128549.html
Releted News by prnewswire
This Is a Test From PR Newswire, Please Disregard - BB
This Is a Test From PR Newswire, Please Disregard - CC
After a successful launch of $500mil liquidity, SashimiSwap unveils its new strategy and Roadmap
Nestlé commences tender offer for Aimmune Therapeutics, Inc.
PlayDapp Launches RPG 'Along with the Gods: knights of the Dawn' on Google Play Store
Olin Announces Partial Redemption Of 9.75% Senior Notes Due 2023
Consumption Volume and Market Value Trends in the Global Gouda Market